Tego Biosciences sells intellectual property portfolio to Luna Innovations (News-Medical-Net)

Arrowhead Research Corporation today announced that its wholly owned subsidiary, Tego Biosciences, has completed a definitive asset purchase agreement for the sale of its non-cash intellectual property (IP) to Luna Innovations, Inc., a developer and manufacturer of new-generation products that include pharmaceutical nanomedicines
(read the story…)

Related items

• Arrowhead Research Corporation Subsidiary Tego Biosciences Sells IP Portfolio to Luna Innovations (Business Wire via Yahoo! Finance)
• Celsion’s Technology Is The Focus Of 6.4 Million EUR ‘HIFU-CHEM’ Program To Study ThermoDox(R) And MRI-guided HIFU (Medical News Today)
• Arrowhead Reports Fiscal 2009 Fourth Quarter and Full-Year Financial Results (Business Wire via Yahoo! Finance)
• Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors (Business Wire via Yahoo! Finance)
• Arrowhead Receives Additional 180-Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement (Business Wire via Yahoo! Finance)

Tags: Arrowhead, arrowhead research, asset purchase agreement, Corporation, generation products, innovations inc, Luna Innovations, medicin, medicine, nano, nanotech, nanotechnologie, nanotechnologies, Research, subsidiary, today

This entry was posted on Tuesday, December 29th, 2009 at 7:50 pm and is filed under Business.